Navigation Links
Lilly Reports Solid First-Quarter Results
Date:4/21/2008

N/M

Asset impairments,

restructuring and other

special charges 145.7 123.0 N/M

--------- ---------

Operating income 1,036.0 681.1 52 %

Net interest income

(expense) (3.5) 4.0

Joint-venture income 0.0 11.0

Net other income 23.8 23.3

--------- ---------

Other income 20.3 38.3

Income before income taxes 1,056.3 719.4 47 %

Income taxes (8.0) 210.7 N/M

--------- ---------

Net income $ 1,064.3 $ 508.7 109 %

--------- ---------

Earnings per share -

basic $ 0.97 $ 0.47 106 %

--------- ---------

Earnings per share -

diluted $ 0.97 $ 0.47 106 %

--------- ---------

Dividends paid per share $ 0.47 $ 0.425 11 %

Weighted-average shares

outstanding (thousands) -

basic 1,093,866 1,089,732

Weighted-average shares

outstanding (thousands) -

diluted 1,094,056 1,089,879

N/M - not meaningful

Eli Lilly and Company

Operating Results (Unaudited) - PRO FORMA

(Dollars in millions, except per share data)

Three Months Ended

March 31

2008 2007(a) % Chg.

--------------------------------

Net sales $ 4,807.6 $ 4,298.8 12 % '/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
2. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
3. Lilly Announces Termination of AIR Insulin Program
4. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
7. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
8. Lilly Declares Fourth-Quarter Dividend
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Belmont, MA (PRWEB) May 21, 2013 ... complete tracking to reporting eLearning solution using Tin ... report and dashboard tool. CLD is a leading ... biotech, and medical device companies worldwide. , ... tracking standard that helps learners and trainers more ...
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... for the 13th consecutive year at the Association ... Conference and Expo. The conference brings together professionals ... technologies. This year’s event will be held from ... The three-day event draws over 1,500 healthcare technology ...
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... May 21, 2013 As the ... strong push within the industry to deliver better ... Organizations and pharma companies often means turning big ... Microtablets, developed in collaboration with Sensidose AB and ... can bring products to market sooner. The partnership ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... Progress of Ongoing Programmes Confirmed, REINACH and ... presents two clinical posters on its late-stage,investigational antibiotic ... (Verbund Klinische Pharmakologie - VKliPha) which takes place,1-3 ... the conference,further expand the substantial volume of data ...
... major cause of death among men. Based on the ... will be the No. 1 cause of death for ... Universiteit Leuven, in collaboration with the Flemish biotech company ... This substance appears not only to be successful in ...
... the carbon nanotube, a team of researchers has crafted ... material. , Fixed between two electrodes, the vibrating tube ... tunable filter, amplifier and demodulator--to tune in a radio ... through an attached speaker. , Functional across a bandwidth ...
Cached Biology Technology:Arpida Presents Data on Iclaprim at Scientific Congress in Germany 2Arpida Presents Data on Iclaprim at Scientific Congress in Germany 3Arpida Presents Data on Iclaprim at Scientific Congress in Germany 4On the road to a new cancer therapy -- starving the tumor 2On the road to a new cancer therapy -- starving the tumor 3World's smallest radio fits in the palm of the hand...of an ant 2World's smallest radio fits in the palm of the hand...of an ant 3
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... population peaks on the edges of the gypsy moth range ... to a team of researchers. , "Slowing the spread of ... the U.S.," says Ottar Bjornstad, associate professor of entomology and ... spread of invasive species is important for successful management." ...
... individuals lacking in B-vitamins ?including college athletes and ... high-intensity exercise and have a decreased ability to ... diets, according to recent Oregon State University research ... and Exercise Metabolism. , The B-vitamins include thiamin, ...
... and his collaborators have resolved key questions regarding transcription, the ... Nobel Prize in Chemistry. , Transcription is the first ... out the out instructions contained in genes. Transcription is carried ... synthesizes an RNA copy of the information in DNA. ...
Cached Biology News:Edge density key to controlling gypsy moth spread 2Poor athletic performance linked to vitamin deficiency 2Nanotech tools yield DNA transcription breakthrough 2Nanotech tools yield DNA transcription breakthrough 3Nanotech tools yield DNA transcription breakthrough 4
Rb anti-Occludin (C-term GST)...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
...
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Biology Products: